Cargando…

Cerliponase alfa for neuronal ceroid lipofuscinosis type 2 disease

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	NPS MedicineWise 2019
Materias:	New Drug
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594840/ https://www.ncbi.nlm.nih.gov/pubmed/31363309 http://dx.doi.org/10.18773/austprescr.2019.029

Ejemplares similares

Presymptomatic treatment of classic late-infantile neuronal ceroid lipofuscinosis with cerliponase alfa
por: Schaefers, J., et al.
Publicado: (2021)

MRI findings in neuronal ceroid lipofuscinosis
por: Crain, Anna M., et al.
Publicado: (2020)

Neuronal ceroid lipofuscinosis type 2: an Australian case series
por: Johnson, Alexandra M, et al.
Publicado: (2020)

Juvenile neuronal ceroid lipofuscinosis (Batten disease): current insights
por: Ostergaard, John R
Publicado: (2016)

Molecular epidemiology of childhood neuronal ceroid-lipofuscinosis in Italy
por: Santorelli, Filippo Maria, et al.
Publicado: (2013)

MRI findings of neuronal ceroid lipofuscinosis in a cat
por: White, Crystal, et al.
Publicado: (2018)

OPTICAL COHERENCE TOMOGRAPHY IN JUVENILE NEURONAL CEROID LIPOFUSCINOSIS
por: Hansen, Michael S., et al.
Publicado: (2016)

Editorial: Neuronal ceroid lipofuscinosis: A multidisciplinary update
por: Simonati, Alessandro, et al.
Publicado: (2022)

Heterozygosity for neuronal ceroid lipofuscinosis predisposes to bipolar disorder
por: Privitera, Flavia, et al.
Publicado: (2023)

Retinal degeneration in mice and humans with neuronal ceroid lipofuscinosis type 8
por: Salpeter, Elyse M., et al.
Publicado: (2021)

Moving towards effective therapeutic strategies for Neuronal Ceroid Lipofuscinosis
por: Geraets, Ryan D., et al.
Publicado: (2016)

Mutated CTSF in adult-onset neuronal ceroid lipofuscinosis and FTD
por: van der Zee, Julie, et al.
Publicado: (2016)

Adult-Onset Neuronal Ceroid Lipofuscinosis in a Shikoku Inu
por: Tamura, Shinji, et al.
Publicado: (2021)

Neuronal Ceroid Lipofuscinosis: The Multifaceted Approach to the Clinical Issues, an Overview
por: Simonati, Alessandro, et al.
Publicado: (2022)

Glial cells are functionally impaired in juvenile neuronal ceroid lipofuscinosis and detrimental to neurons
por: Parviainen, Lotta, et al.
Publicado: (2017)

An ERG and OCT study of neuronal ceroid lipofuscinosis CLN2 Battens retinopathy
por: Thompson, Dorothy A., et al.
Publicado: (2021)

Novel CLN1 mutation with atypical juvenile neuronal ceroid lipofuscinosis
por: Khan, Arif, et al.
Publicado: (2013)

Atypical juvenile neuronal ceroid lipofuscinosis: A report of three cases
por: Setty, Gururaj, et al.
Publicado: (2013)

Fingolimod and Teriflunomide Attenuate Neurodegeneration in Mouse Models of Neuronal Ceroid Lipofuscinosis
por: Groh, Janos, et al.
Publicado: (2017)

Screening and Carrier Rate of Neuronal Ceroid Lipofuscinosis in Chihuahua Dogs in Japan
por: Pervin, Shahnaj, et al.
Publicado: (2022)

Neuronal ceroid lipofuscinosis in the South American-Caribbean region: An epidemiological overview
por: Guelbert, Guillermo, et al.
Publicado: (2022)

Buffy Coat Score as a Biomarker of Treatment Response in Neuronal Ceroid Lipofuscinosis Type 2
por: Sivananthan, Siyamini, et al.
Publicado: (2023)

Cerliponase Alfa for the Treatment of Atypical Phenotypes of CLN2 Disease: A Retrospective Case Series
por: Wibbeler, Eva, et al.
Publicado: (2020)

Multiple cranial nerve enhancement in a case of neuronal ceroid lipofuscinosis type 8
por: Alsini, Hanin, et al.
Publicado: (2022)

Atypical Parkinsonism with Pathological Dopamine Transporter Imaging in Neuronal Ceroid Lipofuscinosis Type 5
por: Lange, Lara M., et al.
Publicado: (2022)

Etiology of anxious and fearful behavior in juvenile neuronal ceroid lipofuscinosis (CLN3 disease)
por: Ostergaard, John R.
Publicado: (2023)

Compromised astrocyte function and survival negatively impact neurons in infantile neuronal ceroid lipofuscinosis
por: Lange, Jenny, et al.
Publicado: (2018)

Mutation of the parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis
por: Bras, Jose, et al.
Publicado: (2012)

Correction: An ERG and OCT study of neuronal ceroid lipofuscinosis CLN2 Battens retinopathy
por: Thompson, Dorothy A., et al.
Publicado: (2021)

Clinical Pharmacokinetics and Pharmacodynamics of Cerliponase Alfa, Enzyme Replacement Therapy for CLN2 Disease by Intracerebroventricular Administration
por: Kim, Aryun, et al.
Publicado: (2020)

Developmental NMDA receptor dysregulation in the infantile neuronal ceroid lipofuscinosis mouse model
por: Koster, Kevin P, et al.
Publicado: (2019)

Imaging gene delivery in a mouse model of congenital neuronal ceroid lipofuscinosis
por: Pike, Lisa S., et al.
Publicado: (2011)

Native and Complexed IGF-1: Biodistribution and Pharmacokinetics in Infantile Neuronal Ceroid Lipofuscinosis
por: Huhtala, Tuulia, et al.
Publicado: (2012)

Evidence for Aberrant Astrocyte Hemichannel Activity in Juvenile Neuronal Ceroid Lipofuscinosis (JNCL)
por: Burkovetskaya, Maria, et al.
Publicado: (2014)

Late infantile neuronal ceroid lipofuscinosis: A case report with review of literature
por: Verma, Rajesh, et al.
Publicado: (2013)

Cardiac magnetic resonance findings in neuronal ceroid lipofuscinosis: A case report
por: Todiere, Giancarlo, et al.
Publicado: (2022)

Neuronal ceroid lipofuscinosis assessment utilizing virtual visits during a pandemic
por: Vierhile, Amy, et al.
Publicado: (2021)

Strategies to treat neurodegeneration in neuronal ceroid lipofuscinosis: a view onto the retina
por: Bartsch, Udo
Publicado: (2022)

The involvement of Purkinje cells in progressive myoclonic epilepsy: Focus on neuronal ceroid lipofuscinosis
por: Bernardi, Sara, et al.
Publicado: (2023)

“Real world effectiveness of cerliponase alfa in classical and atypical patients. A case series”
por: Espitia Segura, O.M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ejotj67r76e0er2pu36h5u3ftv